Nebius Stock Jumps 9% on AI Compute Price Hikes as Analysts Weigh Crash Opportunity

1 hour ago 2 sources neutral

Key takeaways:

  • Nebius price hikes reveal AI compute supply tightness, yet 45x sales demands flawless execution.
  • CoreWeave and IREN gains suggest sector sympathy, yet differentiation will decide winners.
  • Insider selling with zero purchases and negative FCF caution against chasing NBIS's technical rebound.

Nebius Group (NBIS) stock rose roughly 9% in pre-market trading on September 17, 2026, after reports emerged that the AI cloud provider is raising prices across its compute offerings effective October 1. The changes cover GPU, CPU, and memory resources and were first circulated on X and Reddit before being picked up by financial media.

Under the new pricing, Nvidia H100 GPU rates increase about 17% to $4.50 per GPU-hour, H200 rises 20% to $5.40, B200 gains 19% to $8.50, and B300 jumps 21% to $9.50 per GPU-hour. AMD EPYC Genoa CPU pricing moves up 25% to $0.015 per vCPU-hour, while Genoa memory pricing climbs around 41% to $0.0045 per GiB-hour.

The announcement lifted peers in the AI infrastructure space: CoreWeave rose about 6% and IREN climbed around 5% in pre-market action. Nebius had already posted Q2 2026 revenue of $582 million, a 454% year-over-year increase, with AI cloud revenue surging 514%. The company expects $9 billion in customer prepayments in 2026 and raised its contracted power target for 2026 to 5 GW, from more than 4 GW previously, with plans to deploy more than 1 GW per year starting in 2027. Q2 capex came in at $5.7 billion, above the $4.7 billion analyst estimate.

Despite the strong operational growth, valuation metrics remain stretched: the stock carries a price-to-sales ratio of about 45.35 versus a historical median of 6.79, with negative EPS and negative free cash flow. Insider activity showed $173 million in stock sold over the past 12 months and no insider purchases, while eight institutional holders held NBIS and seven had recently added to positions.

A separate analyst view noted that NBIS had fallen more than 30% from its 2026 high of $300 to around $209–$220, pressured by broader AI safety concerns. Executives including Dario Amodei, Sam Altman, and Elon Musk have called for guardrails, and Anthropic reported identifying biological research conducted on its Claude platform, fueling the sell-off. Technical analysts highlighted that NBIS remained above the 50% Fibonacci retracement level near $187 and the 100-day exponential moving average. They also pointed to a possible inverted head-and-shoulders pattern, suggesting a potential rebound toward the $300 psychological level.

Disclaimer

The content on this website is provided for information purposes only and does not constitute investment advice, an offer, or professional consultation. Crypto assets are high-risk and volatile — you may lose all funds. Some materials may include summaries and links to third-party sources; we are not responsible for their content or accuracy. Any decisions you make are at your own risk. Coinalertnews recommends independently verifying information and consulting with a professional before making any financial decisions based on this content.